(XRX) Xerox - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US98421M1062
Printers, Copiers, Software, Services, Financing
Dividends
| Dividend Yield | 16.13% |
| Yield on Cost 5y | 2.65% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 81.3% |
| Payout Ratio | 94.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 65.9% |
| Value at Risk 5%th | 94.6% |
| Relative Tail Risk | -12.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.30 |
| Alpha | -90.18 |
| CAGR/Max DD | -0.47 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.479 |
| Beta | 1.693 |
| Beta Downside | 1.338 |
| Drawdowns 3y | |
|---|---|
| Max DD | 86.50% |
| Mean DD | 36.37% |
| Median DD | 29.99% |
Description: XRX Xerox October 22, 2025
Xerox Holdings Corp. (NASDAQ:XRX) is a global workplace-technology firm that blends hardware, software, and services across two segments-Print & Other and Xerox Financial Services (XFS). Its portfolio spans entry-level A4 printers, mid-range A3 devices, ConnectKey software, production presses, Managed Print Services, IT solutions, and financing options for both direct and indirect channel customers.
Key recent metrics: FY 2023 revenue was approximately $9.3 billion, with services and solutions contributing roughly 45 % of that total and growing at a 6 % YoY rate, while traditional print hardware declined about 4 % amid corporate cost-cutting and a broader shift toward digital document workflows. The company’s operating margin improved to 6.8 % after a restructuring that emphasized recurring-revenue models, and its free-cash-flow conversion hovered near 55 %-a notable outperformance versus the average 40 % seen in the broader technology-hardware sector. Macro-level drivers include sustained enterprise spending on automation, rising interest-rate sensitivity that can affect XFS financing demand, and supply-chain pressures that favor vendors with diversified component sourcing.
For a deeper quantitative dive, the ValueRay platform offers a granular breakdown of XRX’s cash-flow trends and peer-adjusted multiples.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-977.0m TTM) > 0 and > 6% of Revenue (6% = 396.4m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -2.91pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.36% (prev 9.70%; Δ -4.34pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 410.0m > Net Income -977.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.93b) to EBITDA (89.0m) ratio: 44.12 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.10 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (125.8m) change vs 12m ago 1.16% (target <= -2.0% for YES) |
| Gross Margin 38.47% (prev 32.17%; Δ 6.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 71.85% (prev 76.58%; Δ -4.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.17 (EBITDA TTM 89.0m / Interest Expense TTM 199.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.79
| (A) 0.04 = (Total Current Assets 3.75b - Total Current Liabilities 3.40b) / Total Assets 10.07b |
| (B) 0.25 = Retained Earnings (Balance) 2.52b / Total Assets 10.07b |
| (C) -0.03 = EBIT TTM -232.0m / Avg Total Assets 9.20b |
| (D) -0.09 = Book Value of Equity -806.0m / Total Liabilities 9.47b |
| Total Rating: 0.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.28
| 1. Piotroski 3.0pt |
| 2. FCF Yield 7.63% |
| 3. FCF Margin 4.93% |
| 4. Debt/Equity 7.61 |
| 5. Debt/Ebitda 44.12 |
| 6. ROIC - WACC (= -4.64)% |
| 7. RoE -87.39% |
| 8. Rev. Trend -37.39% |
| 9. EPS Trend -33.16% |
What is the price of XRX shares?
As of December 06, 2025, the stock is trading at USD 2.79 with a total of 2,040,976 shares traded.
Over the past week, the price has changed by +0.36%, over one month by -5.74%, over three months by -27.61% and over the past year by -66.14%.
Over the past week, the price has changed by +0.36%, over one month by -5.74%, over three months by -27.61% and over the past year by -66.14%.
Is XRX a buy, sell or hold?
Xerox has received a consensus analysts rating of 2.80.
Therefor, it is recommend to hold XRX.
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the XRX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.8 | 34.4% |
| Analysts Target Price | 3.8 | 34.4% |
| ValueRay Target Price | 2.1 | -23.7% |
XRX Fundamental Data Overview December 05, 2025
Market Cap USD = 347.0m (347.0m USD * 1.0 USD.USD)
P/E Forward = 2.6069
P/S = 0.0525
P/B = 0.9366
P/EG = 0.1984
Beta = 1.743
Revenue TTM = 6.61b USD
EBIT TTM = -232.0m USD
EBITDA TTM = 89.0m USD
Long Term Debt = 4.05b USD (from longTermDebt, last quarter)
Short Term Debt = 354.0m USD (from shortTermDebt, last quarter)
Debt = 4.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.93b USD (from netDebt column, last quarter)
Enterprise Value = 4.27b USD (347.0m + Debt 4.41b - CCE 479.0m)
Interest Coverage Ratio = -1.17 (Ebit TTM -232.0m / Interest Expense TTM 199.0m)
FCF Yield = 7.63% (FCF TTM 326.0m / Enterprise Value 4.27b)
FCF Margin = 4.93% (FCF TTM 326.0m / Revenue TTM 6.61b)
Net Margin = -14.79% (Net Income TTM -977.0m / Revenue TTM 6.61b)
Gross Margin = 38.47% ((Revenue TTM 6.61b - Cost of Revenue TTM 4.07b) / Revenue TTM)
Gross Margin QoQ = 59.82% (prev 27.98%)
Tobins Q-Ratio = 0.42 (Enterprise Value 4.27b / Total Assets 10.07b)
Interest Expense / Debt = 1.82% (Interest Expense 80.0m / Debt 4.41b)
Taxrate = -153.3% (out of range, set to none) (460.0m / -300.0m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.10 (Total Current Assets 3.75b / Total Current Liabilities 3.40b)
Debt / Equity = 7.61 (Debt 4.41b / totalStockholderEquity, last quarter 579.0m)
Debt / EBITDA = 44.12 (Net Debt 3.93b / EBITDA 89.0m)
Debt / FCF = 12.05 (Net Debt 3.93b / FCF TTM 326.0m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.70% (Net Income -977.0m / Total Assets 10.07b)
RoE = -87.39% (Net Income TTM -977.0m / Total Stockholder Equity 1.12b)
RoCE = -4.49% (EBIT -232.0m / Capital Employed (Equity 1.12b + L.T.Debt 4.05b))
RoIC = -3.75% (negative operating profit) (EBIT -232.0m / (Assets 10.07b - Curr.Liab 3.40b - Cash 479.0m))
WACC = 0.90% (E(347.0m)/V(4.75b) * Re(12.26%) + (debt cost/tax rate unavailable))
Discount Rate = 12.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.10%
[DCF Debug] Terminal Value 65.19% ; FCFE base≈400.4m ; Y1≈415.9m ; Y5≈476.2m
Fair Price DCF = 35.59 (DCF Value 4.56b / Shares Outstanding 128.0m; 5y FCF grow 4.06% → 3.0% )
EPS Correlation: -33.16 | EPS CAGR: -13.19% | SUE: 1.56 | # QB: 1
Revenue Correlation: -37.39 | Revenue CAGR: 2.66% | SUE: -1.62 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=-0.270 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.07 | Chg30d=-0.461 | Revisions Net=+0 | Growth EPS=+373.4% | Growth Revenue=+12.1%
P/E Forward = 2.6069
P/S = 0.0525
P/B = 0.9366
P/EG = 0.1984
Beta = 1.743
Revenue TTM = 6.61b USD
EBIT TTM = -232.0m USD
EBITDA TTM = 89.0m USD
Long Term Debt = 4.05b USD (from longTermDebt, last quarter)
Short Term Debt = 354.0m USD (from shortTermDebt, last quarter)
Debt = 4.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.93b USD (from netDebt column, last quarter)
Enterprise Value = 4.27b USD (347.0m + Debt 4.41b - CCE 479.0m)
Interest Coverage Ratio = -1.17 (Ebit TTM -232.0m / Interest Expense TTM 199.0m)
FCF Yield = 7.63% (FCF TTM 326.0m / Enterprise Value 4.27b)
FCF Margin = 4.93% (FCF TTM 326.0m / Revenue TTM 6.61b)
Net Margin = -14.79% (Net Income TTM -977.0m / Revenue TTM 6.61b)
Gross Margin = 38.47% ((Revenue TTM 6.61b - Cost of Revenue TTM 4.07b) / Revenue TTM)
Gross Margin QoQ = 59.82% (prev 27.98%)
Tobins Q-Ratio = 0.42 (Enterprise Value 4.27b / Total Assets 10.07b)
Interest Expense / Debt = 1.82% (Interest Expense 80.0m / Debt 4.41b)
Taxrate = -153.3% (out of range, set to none) (460.0m / -300.0m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.10 (Total Current Assets 3.75b / Total Current Liabilities 3.40b)
Debt / Equity = 7.61 (Debt 4.41b / totalStockholderEquity, last quarter 579.0m)
Debt / EBITDA = 44.12 (Net Debt 3.93b / EBITDA 89.0m)
Debt / FCF = 12.05 (Net Debt 3.93b / FCF TTM 326.0m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.70% (Net Income -977.0m / Total Assets 10.07b)
RoE = -87.39% (Net Income TTM -977.0m / Total Stockholder Equity 1.12b)
RoCE = -4.49% (EBIT -232.0m / Capital Employed (Equity 1.12b + L.T.Debt 4.05b))
RoIC = -3.75% (negative operating profit) (EBIT -232.0m / (Assets 10.07b - Curr.Liab 3.40b - Cash 479.0m))
WACC = 0.90% (E(347.0m)/V(4.75b) * Re(12.26%) + (debt cost/tax rate unavailable))
Discount Rate = 12.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.10%
[DCF Debug] Terminal Value 65.19% ; FCFE base≈400.4m ; Y1≈415.9m ; Y5≈476.2m
Fair Price DCF = 35.59 (DCF Value 4.56b / Shares Outstanding 128.0m; 5y FCF grow 4.06% → 3.0% )
EPS Correlation: -33.16 | EPS CAGR: -13.19% | SUE: 1.56 | # QB: 1
Revenue Correlation: -37.39 | Revenue CAGR: 2.66% | SUE: -1.62 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=-0.270 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.07 | Chg30d=-0.461 | Revisions Net=+0 | Growth EPS=+373.4% | Growth Revenue=+12.1%
Additional Sources for XRX Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle